A detailed history of Norinchukin Bank, The transactions in Moderna, Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 14,040 shares of MRNA stock, worth $1.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,040
Previous 14,322 1.97%
Holding current value
$1.66 Million
Previous $1.42 Million 5.06%
% of portfolio
0.05%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $24,074 - $32,554
-282 Reduced 1.97%
14,040 $1.5 Million
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $75,487 - $113,410
-1,086 Reduced 7.05%
14,322 $1.42 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $1.49 Million - $1.95 Million
15,408 New
15,408 $1.59 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $587,049 - $795,265
-4,954 Reduced 20.03%
19,785 $2.4 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $91,977 - $133,579
678 Added 2.82%
24,739 $3.8 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $516,610 - $916,614
-4,364 Reduced 15.35%
24,061 $4.32 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $177,813 - $292,435
1,506 Added 5.59%
28,425 $3.36 Million
Q2 2022

Aug 10, 2022

SELL
$117.13 - $176.59 $1.12 Million - $1.68 Million
-9,524 Reduced 26.13%
26,919 $3.85 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $467,522 - $868,979
3,697 Added 11.29%
36,443 $6.28 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $480,544 - $784,189
-2,128 Reduced 6.1%
32,746 $8.32 Million
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $6.71 Million - $14.7 Million
30,260 Added 655.83%
34,874 $13.4 Million
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $92,236 - $166,835
710 Added 18.19%
4,614 $1.08 Million
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $133,527 - $227,453
1,223 Added 45.62%
3,904 $511,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $176,248 - $455,394
2,681 New
2,681 $280,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.